Clearwater International advises CAM Bioceramics on the sale of its Chinese activities to Orchid

Clearwater International advises Cam Bioceramics on the sale of its Chinese activities to Orchid

Clearwater International has advised Cam Bioceramics, a global orthobiologic innovator, on the sale of its Chinese production facility and operations, Cam China, to Orchid Orthopedic Solutions (Orchid), a worldwide leader in orthopaedic and medical devices.

Based in the Netherlands, Cam Bioceramics is a global orthobiologic materials innovator that specialises in calcium phosphates.

Headquartered in the US, Orchid is a worldwide leader in the design and manufacture of products for the orthopaedic and medical device industries. With over 1,800 skilled employees and 15 production facilities, Orchid generates a turnover of around €270m.

With the acquisition of Cam China, Orchid further strengthens its role as a global, coating leader for the orthopaedic and medical device industries. It also enables Cam Bioceramics to focus on its core business of engineering, development, and contract manufacturing of orthobiologic calcium compositions.

  • Image of CAM Bioceramics Company Logo
    sold its Chinese activities to
    Image of Orchid Company Logo
    Sell-side
    Undisclosed
    View Back of Transaction
    Clearwater顾问

    Adviser to CAM Bioceramics on the sale of its Chinese activities to Orchid

    查看更多